← Open Payments lookup

KATHRYN SYED: Open Payments

NPI 1700173440 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,978 in 117 payments from 16 companies in 2025. Trend: 2023 $2,763 · 2024 $2,407 · 2025 $1,978

Food & beverage: $1,978
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.14$320
Alkermes, Inc.17$303
Teva Pharmaceuticals USA, Inc.30$287
Janssen Pharmaceuticals, Inc12$220
Otsuka America Pharmaceutical, Inc.9$183
E.R. Squibb & Sons, L.L.C.9$175
ABBVIE INC.6$112
AstraZeneca Pharmaceuticals LP5$88
Braeburn Inc.3$66
Indivior Inc.4$66

Products named: INGREZZA, INVEGA SUSTENNA, ARISTADA, UZEDY, COBENFY, VRAYLAR, ABILIFY ASIMTUFII, AUSTEDO XR.

Industry payments across FL — which companies pay providers there.